The UK Government is set to offer a new grant through the Industrial Strategy Challenge Fund (ISCF) to create new manufacturing facilities to accelerate drug development.
Announced by new Universities and Science Minister Sam Gyimah, the £70m funding will also be utilised for new medical projects such as use of virtual reality to aid in patient recovery and digital speech therapy for stroke and brain injuries.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The investment is expected to increase the number of job opportunities, bolster the National Health Service (NHS) and improve care for patients.
It forms part of the government’s upcoming UK Research and Innovation (UKRI) Research and Innovation Infrastructure Roadmap Programme, which will include development of scientific facilities, major equipment, scientific data, e-infrastructures and communications networks by 2019.
Gyimah said: “This investment will not only support high-value, highly skilled jobs but will develop lifesaving treatments that could change lives across the UK.
“Through our ambitious, modern Industrial Strategy we want to unlock the innovations that will help people live better, longer lives by developing the medicines of the future.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“We want to improve the way we make medicines and we are determined to capitalise on our research and innovation infrastructure, which is why today I am launching the start of the UKRI Research and Innovation Infrastructure Roadmap Programme.”
The minister is set to explore innovative technologies such as cartoon-like robots designed to improve learning and understanding in children with autism, and artificial intelligence (AI) facial-recognition research aiming to detect the onset of depression.
